Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Moleculin Biotech (MBRX) Shares Outstanding (2016 - 2025)

Moleculin Biotech (MBRX) has 10 years of Shares Outstanding data on record, last reported at $49.5 million in Q3 2025.

  • For Q3 2025, Shares Outstanding rose 1548.91% year-over-year to $49.5 million; the TTM value through Sep 2025 reached $49.5 million, up 1548.91%, while the annual FY2024 figure was $3.4 million, 51.69% up from the prior year.
  • Shares Outstanding reached $49.5 million in Q3 2025 per MBRX's latest filing, up from $30.2 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $49.5 million in Q3 2025 and bottomed at $2500.0 in Q2 2021.
  • Average Shares Outstanding over 5 years is $11.9 million, with a median of $2.6 million recorded in 2024.
  • Peak YoY movement for Shares Outstanding: crashed 93.06% in 2023, then surged 1548.91% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $1.9 million in 2021, then increased by 0.17% to $1.9 million in 2022, then increased by 16.71% to $2.2 million in 2023, then surged by 51.69% to $3.4 million in 2024, then skyrocketed by 1364.93% to $49.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $49.5 million in Q3 2025, $30.2 million in Q2 2025, and $14.1 million in Q1 2025.